Literature DB >> 24128984

Chorioamnionitis is essential in the evolution of bronchopulmonary dysplasia--the case in favour.

Wolfgang Thomas1, Christian P Speer2.   

Abstract

Bronchopulmonary dysplasia (BPD) is a major sequel of extremely premature birth. Multiple ante- and postnatal factors act in concert to injure the immature lung in the pathogenesis of the disease. Among them, chorioamnionitis--according to current evidence--plays a pivotal role. Pulmonary inflammatory processes seen in animal models of chorioamnionitis resemble those seen in premature infants who developed BPD. Chorioamnionitis can doubtlessly induce extremely preterm birth, thus contributing to a gestation-dependent risk of BPD. A gestation-independent association of chorioamnionitis with an increased risk of developing BPD has been demonstrated by a recent systematic review of clinical observational studies. Antenatal inflammation with signs of a systemic fetal response reduces the response to exogenous surfactant in infants with respiratory distress syndrome, leading to a longer need for mechanical ventilation. Moreover, chorioamnionitis increases the risk of early onset sepsis. Both mechanical ventilation and sepsis are, however, major postnatal risk factors for BPD.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chronic lung disease of infancy; Fetal inflammatory response syndrome; Prematurity

Mesh:

Year:  2013        PMID: 24128984     DOI: 10.1016/j.prrv.2013.09.004

Source DB:  PubMed          Journal:  Paediatr Respir Rev        ISSN: 1526-0542            Impact factor:   2.726


  28 in total

1.  IL-33-induced neutrophil extracellular traps degrade fibronectin in a murine model of bronchopulmonary dysplasia.

Authors:  Rui Jin; Junjie Xu; Qianqian Gao; Xiaonan Mao; Jiao Yin; Keyu Lu; Yan Guo; Mingshun Zhang; Rui Cheng
Journal:  Cell Death Discov       Date:  2020-05-04

Review 2.  Can We Understand the Pathobiology of Bronchopulmonary Dysplasia?

Authors:  Cristina M Alvira; Rory E Morty
Journal:  J Pediatr       Date:  2017-11       Impact factor: 4.406

3.  Chorioamnionitis and subsequent bronchopulmonary dysplasia in very-low-birth weight infants: a 25-year cohort.

Authors:  A R Ballard; L H Mallett; J E Pruszynski; J B Cantey
Journal:  J Perinatol       Date:  2016-09-01       Impact factor: 2.521

4.  Is bronchopulmonary dysplasia decided before birth?

Authors:  Vineet Bhandari; Abhay Lodha
Journal:  Pediatr Res       Date:  2020-02-17       Impact factor: 3.756

5.  Choriodecidual Group B Streptococcal Infection Induces miR-155-5p in the Fetal Lung in Macaca nemestrina.

Authors:  Ryan M McAdams; Craig J Bierle; Erica Boldenow; Samantha Weed; Jesse Tsai; Richard P Beyer; James W MacDonald; Theo K Bammler; H Denny Liggitt; Federico M Farin; Jeroen Vanderhoeven; Lakshmi Rajagopal; Kristina M Adams Waldorf
Journal:  Infect Immun       Date:  2015-07-20       Impact factor: 3.441

Review 6.  Postnatal inflammation in the pathogenesis of bronchopulmonary dysplasia.

Authors:  Vineet Bhandari
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2014-02-27

Review 7.  Can maternal DHA supplementation offer long-term protection against neonatal hyperoxic lung injury?

Authors:  Krithika Lingappan; Bhagavatula Moorthy
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-09-11       Impact factor: 5.464

Review 8.  Animal models of bronchopulmonary dysplasia. The preterm baboon models.

Authors:  Bradley A Yoder; Jacqueline J Coalson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-10-03       Impact factor: 5.464

Review 9.  Placental origins of neonatal diseases: toward a precision medicine approach.

Authors:  Imran N Mir; Rachel Leon; Lina F Chalak
Journal:  Pediatr Res       Date:  2020-12-07       Impact factor: 3.756

10.  Chorioamnionitis induces changes in ovine pulmonary endogenous epithelial stem/progenitor cells in utero.

Authors:  Helene Widowski; Daan R M G Ophelders; Anaïs J C N van Leeuwen; Peter G J Nikkels; Carmen A H Severens-Rijvers; Vanessa L S LaPointe; Jack P M Cleutjens; Matthias C Hütten; Matthew W Kemp; Matthew S Payne; Masatoshi Saito; Haruo Usuda; John P Newnham; Alan H Jobe; Boris W Kramer; Tammo Delhaas; Tim G A M Wolfs; Niki L Reynaert
Journal:  Pediatr Res       Date:  2020-10-18       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.